| Recruiting | 2 | 89 | Europe, RoW | Mylotarg, GO, Arsenic Trioxide, ATO, All-trans retinoic acid, ATRA | Associazione Italiana Ematologia Oncologia Pediatrica, AIEOP | Acute Promyelocytic Leukemia | 10/25 | 10/27 | | |
NCT03590171: International Study for Treatment of High Risk Childhood Relapsed ALL 2010 |
|
|
| Recruiting | 2 | 250 | Europe, RoW | Bortezomib | Charite University, Berlin, Germany, Australian & New Zealand Children's Haematology/Oncology Group, St. Anna Kinderkrebsforschung, CCRI (co-sponsor, Austria), European Organisation for Research and Treatment of Cancer - EORTC, University Hospital Motol (Co-Sponsor Czech Republic), Copenhagen University Hospital, Rigshospitalet (co-sponsor, Denmark), Turku University Central Hospital (co-sponsor, Finland), Centre Hospitalier Universitaire de Nice, Our Lady's Chilrden's Hospital (Co-Sponsor Ireland), Tel Aviv Sourasky Medical Centre (Co-Sponsor Israel), Ospedale Pediatrico Bambino (co-sponsor, Italy), Prinses Máxima Centrum (Co-Sponsor Netherlands), Oslo University Hospital (co-sponsor, Norway), Medical University of Wroclaw (Co-Sponsor Poland), Instituto Português de Oncologia de Lisboa (co-sponsor, Portugal), Karolinska University Hospital Stockholm (co-sponsor, Sweden), Spanish Society of Pediatric Hematology and Oncology (SEHOP) (Co-Sponsor Spain), University Children's Hospital, Zurich, Central Manchester University Hospitals NHS Foundation Trust (co-sponsor, UK) | Acute Lymphoblastic Leukemia (ALL) | 12/27 | 12/27 | | |